BeStock  

Prestige Consumer Healthcare PBH

US equityMarket cap rank #2587Drug Manufacturers - Specialty & Generic
$49.63 +$0.03 (+0.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $49.63 0.00%
Open$49.85
Prev close$49.60
Day range$49.43 – $51.23
Volume612.4K
Market cap$2.35B
P/E (TTM)15.3
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Sep 2026

Revenue$336.31M+22.7% YoY
Operating profit$80.71M+1.3% YoY
Net profit$25.30M-40.1% YoY
Diluted EPS$0.53-38.4% YoY
Free cash flow$34.24M-38.2% YoY
Operating cash flow$37.87M

Revenue, last 8 quarters

$290.3MDec '24$296.5MMar '25$249.5MJun '25$274.1MSep '25$283.4MDec '25$281.6MMar '26$265.7MJun '26$336.3MSep '26

Net profit, last 8 quarters

$61.0MDec '24$50.1MMar '25$47.5MJun '25$42.2MSep '25$46.7MDec '25$53.9MMar '26$29.2MJun '26$25.3MSep '26

Diluted EPS by quarter

1.22Dec '241.00Mar '250.95Jun '250.86Sep '250.97Dec '251.13Mar '260.61Jun '260.53Sep '26

Free cash flow by quarter

$63.5MDec '24$58.4MMar '25$78.2MJun '25$55.4MSep '25$75.3MDec '25$37.6MMar '26$67.1MJun '26$34.2MSep '26

Annual revenue

$943.4MFY21$1.1BFY22$1.1BFY23$1.1BFY24$1.1BFY25$1.1BFY26

Profitability & balance sheet

Gross margin52.5%
Operating margin25.0%
Net margin13.3%
Return on equity8.2%
Return on assets3.8%
Return on invested capital5.9%
Current ratio2.92
Liabilities / assets58.8%
Cash & investments$46.52M
Total debt$2.12B
Net cash (debt)-$2.07B
Free cash flow / sales18.4%

Where the revenue comes from

Quarter 2027/Q2

By business line

  • North American over-the-counter (OTC) Healthcare$272.71M 80.9%
  • International over-the-counter (OTC) Healthcare$64.50M 19.1%

Income statement

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Revenue as Reported $336.31M $265.71M $1.09B $281.62M $283.44M
Total Operating Revenue $336.31M $265.71M $1.09B $281.62M $283.44M
Cost of Revenue $163.77M $129.52M $493.13M $135.32M $126.08M
Gross Profit $172.54M $136.19M $595.58M $146.30M $157.37M
Operating Expense $91.83M $83.67M $286.17M $70.81M $74.88M
Selling and Admin Expenses $83.12M $77.97M $265.23M $65.37M $69.73M
-Selling & Marketing Expense $52.23M $34.67M $148.78M $35.09M $40.06M
-General & Admin Expense $30.89M $43.30M $116.45M $30.28M $29.67M
Depreciation & Amortization & Depletion $8.71M $5.70M $20.94M $5.44M $5.15M
-Depreciation & Amortization $8.71M $5.70M $20.94M $5.44M $5.15M
Operating Profit $80.71M $52.52M $309.41M $75.49M $82.49M
Net Non-Operating Interest Income (Expense) -$30.03M -$13.95M -$42.34M -$11.43M -$10.67M
Non-Operating Interest Expense $30.03M $13.95M $42.34M $11.43M $10.67M
Other Income (Expense) -$3.24M -$34,000.00 -$9.57M $708,000.00 -$10.01M
Special Income (Charges) -$1.36M – $0.00 – –
-Less:Other Special Charges $1.36M – – – –
Other Non-Operating Income (Expenses) -$1.88M -$34,000.00 -$9.57M $708,000.00 -$10.01M
Pretax Profit $47.45M $38.54M $257.50M $64.77M $61.81M
Tax $22.16M $9.36M $67.20M $10.84M $15.12M
Net Profit $25.30M $29.18M $190.30M $53.93M $46.70M
Profit from Continuing Operations $25.30M $29.18M $190.30M $53.93M $46.70M
Net Income to Parent Company $25.30M $29.18M $190.30M $53.93M $46.70M
Net Income to Common Stockholders $25.30M $29.18M $190.30M $53.93M $46.70M
Basic EPS $0.53 $0.61 $3.93 $1.14 $0.98
Diluted EPS $0.53 $0.61 $3.91 $1.13 $0.97
-Less:Impairment of Capital Assets – – $0.00 – –

Balance sheet

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Assets $4.72B $4.57B $3.49B $3.49B $3.49B
Total Current Assets $492.13M $496.81M $431.48M $431.48M $433.43M
Cash and Cash Equivalents & Short-Term Investments $46.52M $89.13M $63.87M $63.87M $62.37M
-Cash and Cash Equivalents $46.52M $89.13M $63.87M $63.87M $62.37M
Receivables $244.12M $187.36M $191.92M $191.92M $190.46M
-Accounts Receivable $244.12M $187.36M $208.57M $208.57M $190.46M
Inventory $179.20M $190.22M $159.13M $159.13M $163.59M
Other Current Assets $22.29M $30.12M $16.56M $16.56M $17.01M
Total Non-Current Assets $4.23B $4.07B $3.06B $3.06B $3.06B
Net PPE $161.63M $164.17M $171.25M $171.25M $174.74M
-Gross PPE $161.63M $164.17M $260.11M $260.11M $174.74M
Goodwill and Other Intangible Assets $4.06B $3.89B $2.88B $2.88B $2.88B
-Goodwill $705.26M $650.80M $581.11M $581.11M $581.25M
-Other Intangible Assets $3.36B $3.24B $2.30B $2.30B $2.30B
Other Non-Current Assets $5.59M $13.43M $10.87M $10.87M $3.79M
Total Liabilities $2.78B $2.65B $1.61B $1.61B $1.67B
Total Current Liabilities $168.50M $153.81M $120.92M $120.92M $139.56M
Payables $44.90M $44.42M $23.52M $23.52M $43.41M
-Accounts Payable $44.02M $36.85M $22.79M $22.79M $42.95M
-Total Tax Payable $882,000.00 $7.57M $733,000.00 $733,000.00 $466,000.00
Current Accrued Expenses $99.35M $77.99M $72.72M $72.72M $77.10M
Short-Term Debt and Capital Lease Obligation $13.83M $23.80M $12.55M $12.55M $8.63M
-Current Debt $3.87M $14.09M $2.99M $2.99M –
-Current Capital Lease Obligation $9.96M $9.71M $9.57M $9.57M $8.63M
Total Non-Current Liabilities $2.61B $2.50B $1.49B $1.49B $1.53B
Long Term Debt and Capital Lease Obligation $2.11B $2.04B $1.03B $1.03B $1.07B
-Long Term Debt $2.08B $2.01B $993.95M $993.95M $1.03B
-Long Term Capital Lease Obligation $34.09M $36.41M $38.92M $38.92M $37.11M
Non-Current Deferred Liabilities $489.53M $448.82M $447.42M $447.42M $449.33M
Other Non-Current Liabilities $5.55M $5.59M $5.58M $5.58M $5.75M
Total Equity $1.94B $1.92B $1.89B $1.89B $1.83B
Stockholders' Equity $1.94B $1.92B $1.89B $1.89B $1.83B
Capital Stock $563,000.00 $563,000.00 $562,000.00 $562,000.00 $562,000.00
-Common Stock $563,000.00 $563,000.00 $562,000.00 $562,000.00 $562,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $613.84M $612.51M $608.52M $608.52M $605.50M
Retained Earnings $1.80B $1.78B $1.75B $1.75B $1.69B
Less: Treasury Stock -$441.99M -$441.96M -$439.30M -$439.30M -$438.55M
Gains/Losses Not Affecting Retained Earnings -$28.33M -$29.68M -$28.37M -$28.37M -$30.23M
-Loans Receivable – – $0.00 $0.00 –
-Other Receivables – – $1.54M $1.54M –
-Receivables Adjustments Allowances – – -$18.19M -$18.19M –
-Accumulated Depreciation – – -$88.87M -$88.87M –

Cash flow

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Operating Cash Flow $37.87M $70.79M $257.63M $42.84M $78.29M
Net cash flow from continuing operations $37.87M $70.79M $257.63M $42.84M $78.29M
Net Income from Continuing Operations $25.30M $29.18M $190.30M $53.93M $46.70M
Gain/Loss from Continuing Operations $1.50M $191,000.00 $165,000.00 $25,000.00 $9,000.00
Depreciation & Depletion & Amortization $11.96M $8.75M $31.27M $8.35M $7.59M
Deferred Tax $15.27M $193,000.00 $22.70M -$4.11M $3.60M
Other Non-Cash Items $18.11M $5.40M $19.98M $2.49M $12.72M
Change in Working Capital -$35.51M $23.09M -$17.62M -$20.49M $4.94M
-Change in Receivables -$48.84M $3.45M -$3.69M -$1.60M $495,000.00
-Change in Inventory $6.39M -$2.83M -$1.60M $5.47M $3.21M
-Change in Prepaid Assets -$7.74M $1.56M -$6.97M -$55,000.00 $4.85M
-Change in Payables and Accrued Expense $16.79M $23.23M $2.38M -$22.44M -$1.65M
-Change in Other Current Liabilities -$2.09M -$2.10M -$7.78M -$2.00M -$1.94M
-Change In Other Working Capital -$23,000.00 -$233,000.00 $32,000.00 $128,000.00 -$25,000.00
Net cash flow from investing -$138.90M -$1.06B -$136.84M -$3.41M -$128.56M
Net Cash Flow from Continuing Investing Activities -$138.90M -$1.06B -$136.84M -$3.41M -$128.56M
Net PPE Purchase and Sale -$3.62M -$3.70M -$11.18M -$5.21M -$3.03M
Net Business Purchase and Sale -$148.56M -$1.05B -$123.74M $1.80M -$125.53M
Net Other Investing Changes $13.28M -$15.03M -$1.93M $0.00 $0.00
Financing Cash Flow $58.30M $1.02B -$156.06M -$38.10M -$6.73M
Net Cash Flow from Continuing Financing Activities $58.30M $1.02B -$156.06M -$38.10M -$6.73M
Net Issuance Payments Of Debt $64.58M $1.05B $504,000.00 -$37.73M $39.38M
Net Common Stock Issuance $0.00 $0.00 -$156.28M -$690,000.00 -$45.82M
Proceeds from Stock Option Exercised $94,000.00 $0.00 $4.29M $378,000.00 $0.00
Net Other Financing Charges -$6.38M -$26.62M -$4.57M -$62,000.00 -$290,000.00
Ending Cash Balance $46.52M $89.13M $63.87M $63.87M $62.37M
Net Change in Cash -$42.74M $25.51M -$35.28M $1.33M -$57.01M
Beginning Cash Balance $89.13M $63.87M $97.88M $62.37M $119.11M
Effect of Exchange Rate Changes $130,000.00 -$246,000.00 $1.26M $167,000.00 $272,000.00
Free Cash Flow $34.24M $67.09M $246.45M $37.63M $75.26M

Discussion

No comments yet — be the first to weigh in on PBH.

Sign in to join the discussion.

Scroll to Top